Estimated Control Closed Transaction verified Supplements

Avid Health, Inc. acquired by Church & Dwight Co., Inc.

Church & Dwight Co., Inc. acquired Avid Health, Inc., a vitamins & supplements brand, on Oct 1, 2012.

Transaction summary

Target
Avid Health, Inc.
Seller
-
Announced
2012-08-20
Completed
2012-10-01
Geography
-
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-07-13
Latest update
2026-11-01

Value and multiples

100% enterprise value

USD 650M

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

2.83x

Period: LTM 2012

Basis: Public source

EV / EBITDA

11.2x

EBITDA: normalised / adjusted

Basis: Derived from source data

Basis

  • Church & Dwight agreed on 20 August 2012 to buy Avid Health, maker of vitafusion and L'il Critters gummy vitamins, for US$650m in cash, and completed the purchase on 1 October 2012. Multiples use Avid's net sales of about US$230m and EBITDA of about US$58m for the twelve months to 30 June 2012.

Other reviewed estimates

Earlier estimates and their sources.

Thorne HealthTech Schedule 14D-9/A
EBITDA USD 58.0m | EV / EBITDA 11.2x
Open evidence

Source summary

Church & Dwight to Acquire Avid Health, Inc. for $650 Million

Confirmed

Avid’s net sales for the trailing twelve months through June 30, 2012 were approximately $230 million.

Open source

Church & Dwight to Acquire Avid Health, Inc. for $650 Million

Confirmed

Avid’s trailing twelve months EBITDA through June 30, 2012 was approximately $58 million.

Open source

Church & Dwight Form 8-K: completion of the Avid Health acquisition

Confirmed

On October 1, 2012, Church & Dwight Co., Inc. (the “Company”) completed its previously announced acquisition

Open source

Thorne HealthTech Schedule 14D-9/A

Estimated

Canaccord Genuity's selected precedent transactions (US$ in millions) list August 2012, Church & Dwight Co., Inc. and Avid Health, Inc.: implied TEV $650, TEV / LTM Adjusted EBITDA 11.2x.

Open source

Continue your research

Explore more comps →